Abstract
Drug designing is a crucial step in the exploration of novel drugs which requires potent methodologies. One of such methodologies is Quantitative Structure Activity Relationship (QSAR) which is a widely used statistical tool that correlates the structure of a molecule to a biological activity as a function of molecular descriptors, thereby, playing an essential role in the drug designing. QSAR utilizes Density Functional Theory (DFT) based chemical descriptors for this purpose. The selection of such significant molecular descriptors from various available descriptors is the foremost challenge in a QSAR as structural descriptors are representative of the molecular characteristics accountable for the relevant activity. Recently, new QSAR approaches have been introduced which further enhance the study of the activities. Further, the constructed QSAR models also need to be tested and validated for their efficiency and practical usage. As the QSAR models are structure specific, they may not be universally applicable. However, because of their high precision and efficacy, they have a promising future in the world of drug design. This review briefly summarizes the role of descriptor based QSAR in drug design in conjunction with existing QSAR approaches and also the utility as well as constraints of this approach in drug design.
Highlights
Drug designing plays a critical role in medicinal chemistry when it is performed with planning and forethought
This review presents the advancement of Quantitative Structure Activity Relationship (QSAR) in the field of drug designing using quantum chemically derived molecular descriptors
Through utilizing QSAR correlations based on quantum chemical descriptors, one can develop hypothetical structures which either don’t exist or have never been synthesized
Summary
To cite this article: Hiteshi Tandon, Tanmoy Chakraborty, Vandana Suhag. A Concise Review on the Significance of QSAR in Drug Design. Received: December 2, 2019; Accepted: December 16, 2019; Published: December 27, 2019
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.